Status:
COMPLETED
High-Intensity Aerobic Lifelong Training--AF
Lead Sponsor:
University of Minnesota
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study is a single-center RCT. Potential subjects with symptomatic non-permanent AF will be enrolled to determine the effect of sprint interval training (SIT) in comparison to moderate-intensity c...
Detailed Description
Atrial fibrillation (AF) is the most common heart rhythm abnormality in the general population. Current recommended methods to maintain sinus rhythm or reduce AF burden (% time a person is in AF) in p...
Eligibility Criteria
Inclusion
- : Patients with symptomatic non-permanent AF and aged 18-65 years who are sedentary (activity ≤0.5 hours/week of regular exercise) and seen by Dr. Chen or his cardiology colleagues at Clinics and Surgery Center (CSC), other Fairview cardiology clinics, and University of Minnesota Medical Center (UMMC). Patients will be screened and enrolled by a research coordinator.
Exclusion
- Individuals lacking the capacity to consent for themselves will not be included, previous open heart surgery, previous catheter ablation for AF, LVEF \<45%, significant cardiac valve disease, coronary heart disease without complete revascularization, implanted cardiac electronic device, or GFR \<30 mL/min/1.73 m2
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03241433
Start Date
May 1 2018
End Date
December 18 2019
Last Update
December 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455